✓ Medically Reviewed Monograph

Formoterol Fumarate

Also known as / Synonyms: Formoterol Fumarate Dihydrate, Eformoterol, LABA

Long-acting beta-2 agonist (LABA) bronchodilator providing 12-hour airway opening in asthma and COPD.

Medically reviewed by Dr. Lisa Matthews, PharmD BCPS · Clinical Pharmacist
Written by 4mg Clinical Pharmacology Team Last reviewed ✓ Clinically Verified
📋

Clinical Snapshot & Specifications

Generic Name: Formoterol Fumarate
Active Ingredient: Formoterol Fumarate Dihydrate
Dosage Form: Inhaler
Available Strengths: 6 mcg, 12 mcg inhalation powder rotacaps; aerosol inhaler
Prescription Status: Prescription only (Schedule H / verified)
Approved Routes:
Inhaled
Popular Verified Brands:
Foradil Formonide in Foracort Maxiflo (India)
Regulatory Standards: CDSCO approved; Schedule H prescription medicine. Carry black-box warnings internationally regarding monotherapy use in asthma.
🎯

Approved Indications & Medical Uses

  • Long-term maintenance treatment of asthma in patients 5 years and older (strictly combined with an inhaled corticosteroid).
  • Maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.
  • Prevention of exercise-induced bronchospasm (EIB) in adults and adolescents.
🚫

Contraindications (Do Not Use If…)

  • Monotherapy without a long-term asthma controller (such as an inhaled corticosteroid) is contraindicated in asthma.
  • Treatment of acute status asthmaticus or acute severe asthma exacerbations where emergency intensive rescue therapy is required.
  • Known hypersensitivity to formoterol or formulation components.
🛡️

Important Clinical Precautions & Warnings

  • Asthma-related death risk: LABAs used as monotherapy increase the risk of asthma-related death; formoterol must always be prescribed with an inhaled corticosteroid (ICS).
  • Paradoxical bronchospasm: may occur with an immediate increase in wheezing after dosing; treat immediately with an inhaled short-acting bronchodilator and discontinue formoterol.
  • Cardiovascular effects: can produce tachycardia, palpitations, arrhythmia, and ECG changes (QTc prolongation).
  • Hypokalemia and hyperglycemia: transient beta-2 adrenergic stimulation can lower serum potassium and elevate blood glucose.
  • Do not exceed recommended dose: fatal cardiac events have been reported with excessive beta-agonist inhalation.

Special Populations (Paediatric & Geriatric Care)

Pediatric: Approved for asthma maintenance in children >= 5 years strictly in conjunction with an inhaled corticosteroid. Geriatric: No dose adjustments needed, but monitor cardiovascular status closely.

⚡

Side Effects & Adverse Reactions

ℹ️ Common Side Effects (Usually Mild)

Tremor, headache, palpitations, nasopharyngitis, insomnia, throat irritation, dry mouth, and muscle cramps.

🚨 Serious Side Effects — Seek Urgent Medical Care

Paradoxical bronchospasm, severe cardiac arrhythmias (ventricular extrasystoles, atrial fibrillation), myocardial ischemia, significant QTc prolongation, and severe hypokalemia.

Action: Discontinue medication and seek immediate medical attention or call emergency services if any serious symptom occurs.

🔄

Drug, Food & Substance Interactions

  • Other beta-agonists: concurrent use increases sympathetic stimulation and cardiovascular adverse events.
  • Beta-blockers (propranolol, timolol): antagonize formoterol bronchodilation and may produce severe bronchospasm in asthmatic patients.
  • Diuretics (loop/thiazides): co-administration can potentiate acute hypokalemia.
  • Monoamine oxidase inhibitors (MAOIs) and tricyclic antidepressants: prolong QTc interval and potentiate cardiovascular toxicity; administer with extreme caution.
🤰

Pregnancy & Lactation Clinical Safety

Pregnancy Safety:

Use with caution — see notes

Formoterol may interfere with uterine contractility during labor due to beta-2 tocolytic effects. There are no well-controlled studies in pregnant women; use only if potential benefit justifies potential risk.

Lactation & Breastfeeding:

Use with caution — see notes

Excretion in human breast milk is unknown, though detected in animal milk. Administer cautiously to nursing mothers.

📦

Storage, Administration & Overdose Protocol

🌡️ Recommended Storage:

Store inhalation powder capsules at 20°C to 25°C (68°F to 77°F). Protect from moisture and heat. Do not swallow rotacaps; administer via dry powder inhaler only.

⏱️ Missed Dose Protocol:

Take the missed inhalation as soon as remembered. Never take more than 2 capsules at a time, and do not exceed 24 mcg total daily dose.

📚

Clinical Sources & Regulatory References

Statutory drug monograph citations and regulatory databases consulted for clinical synthesis.

Every clinical monograph on 4mg.in is continuously cross-referenced against official pharmacopoeias, national formulary compendia, and statutory regulatory filings to guarantee therapeutic precision:

🏛️ CDSCO (Govt. of India)

Central Drugs Standard Control Organisation, Ministry of Health and Family Welfare. Evaluated for approved indications, Schedule H/H1 status, and National List of Essential Medicines (NLEM).

CDSCO Official Portal →
🇺🇸 U.S. FDA / DailyMed

U.S. Food and Drug Administration Approved Prescribing Information, Package Inserts, and Pharmacovigilance Black Box Warnings repository via NLM DailyMed.

Search FDA Labels on DailyMed →
🌐 World Health Organization

WHO Model List of Essential Medicines (23rd List) and WHO Collaborating Centre for Drug Statistics Methodology (Anatomical Therapeutic Chemical - ATC / DDD Index).

WHO Essential Medicines Registry →
🔬 PubMed / NLM

National Center for Biotechnology Information (NCBI). Peer-reviewed clinical trials, bioavailability investigations, and Cochrane systematic reviews.

Query PubMed Studies for Formoterol Fumarate →
Suggested Monograph Citation:

4mg Clinical Pharmacology Team. Formoterol Fumarate Monograph: Uses, Dosage, Contraindications & Interactions. Medically reviewed by licensed clinical editors. 4mg.in, 2026. Available at: https://4mg.in/medicines/formoterol/

🛡️
Clinical & Legal Disclaimer: The clinical monographs and drug information published on 4mg.in are strictly intended for educational, clinical reference, and informational utility. They do not constitute personalized medical advice, diagnosis, or treatment regimens. Always seek the advice of a registered physician or licensed pharmacist regarding specific clinical conditions, prescription dosages, and potential contraindications. Review our comprehensive Editorial & Clinical Fact-Checking Policy.